Latest in Ozempic picked for Medicare price bargaining
Sort by
570 items
-
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.CNBC - 5h -
Ozempic picked for Medicare price bargaining
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden adds Ozempic to list for Medicare price negotiation In one of its last actions, the Biden administration ...The Hill - 5h -
Obesity drugs Ozempic and Wegovy included in US price-cut talks
Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiationsFinancial Times - 7h -
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.The Wall Street Journal - 12h -
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.The New York Times - 15h -
The next 15 drugs chosen for Medicare negotiation
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare ...The Hill - 13h -
White House says popular weight-loss drug Ozempic subject to Medicare talks
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.MarketWatch - 13h -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - 13h -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - 14h -
CMS to seek Medicare negotiations on Ozempic price
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...The Hill - 15h -
Biden administration picks 15 more drugs for Medicare negotiation
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did ...The Hill - 15h -
Bargain hunting? This value manager has scooped up Airbnb, an AI-healthcare play and a GE spinoff
Five overlooked stocks that the Oakmark Fund unearthed last year.MarketWatch - 1d -
European carmakers call for ‘grand bargain’ with Trump to avoid trade war
Concern over US tariffs heaps pressure on industry struggling with electrification and competition from ChinaFinancial Times - 1d -
How Ozempic Has Forever Changed How Much People Spend on Food, According to a New Cornell University Study
Ozempic doesn’t just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food they buy.Inc. - 1d -
I’m blindsided by extra Medicare charges because of my income. How do I avoid this situation?
A reader is trying to plan ahead to avoid the dreaded IRMAA, a surcharge that can come out of your Social Security check.MarketWatch - 4d -
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?Wired - 4d -
New York City's congestion pricing picks up speed
The first congestion pricing plan in the U.S. has begun, charging most drivers $9 a day to enter the lower half of Manhattan. The long-debated plan is projected to raise up to $800 million a year ...CBS News - 5d -
Baby boomers and ‘Ozempic face’ drive injectables craze
People ‘want to look what they feel like, not what they may look like’ says dermatology giant GaldermaFinancial Times - 5d -
‘He threw a book at me’: Why IRMAA surcharges make seniors on Medicare so mad
Letters will go out soon for those who will have to pay extra next year for their Part B and D premiumsMarketWatch - 6d -
Corrective action is needed to preserve Social Security, Medicare and Medicaid
Any lasting fiscal reforms must moderate the growth of the largest mandatory spending programs: Social Security, Medicare and Medicaid.The Hill - Jan. 10 -
Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.CNBC - Jan. 9 -
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.CNBC - Jan. 9 -
How Trump’s Greenland Plan Could Hit Ozempic, Legos and Hearing Aids
Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular medicines.The New York Times - Jan. 9 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9 -
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.MarketWatch - Jan. 9 -
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...MarketWatch - Jan. 8 -
Johnson says no cuts to Social Security and Medicare to fund Trump's agenda
House Speaker Mike Johnson said cuts to Social Security and Medicare won't be part of the legislative plan being worked out to fund President-elect Donald Trump's agenda.ABC News - Jan. 7 -
Labor Board Says Google Should Have to Bargain With Contractors’ Union
A National Labor Relations Board complaint says that as a joint employer of workers from IT staffing firm Accenture Flex, the tech giant should be obliged to negotiate with its union.Inc. - Jan. 7 -
Citigroup’s stock is a banking-sector bargain as ‘inflection point’ looms, analyst suggests
Barclays analyst Jason Goldberg upgrades Citigroup to overweight from equal weight on bullish 2025 prospects.MarketWatch - Jan. 6 -
Congestion pricing is a New York idea.
A Columbia University economist, William Vickrey, proposed charging varying tolls for roads and subways in the 1950s.The New York Times - Jan. 5 -
N.Y.C. Congestion Pricing Begins on Sunday
After twists and turns, a contentious plan meant to reduce traffic and pay for transit improvements is scheduled to take effect at midnight Sunday.The New York Times - Jan. 4 -
Here are big changes retirees can expect from Social Security and Medicare in 2025
Retirees can expect to see some big changes in 2025 when it comes to their Social Security and Medicare benefits.NBC News - Jan. 4 -
What’s going to happen with Social Security and Medicare in 2025?
What retirees should know about these important benefits heading into the new year.MarketWatch - Jan. 4 -
Here are big changes retirees can expect from Social Security and Medicare in 2025
Millions of beneficiaries can expect enhanced Social Security benefits and new limits to Medicare prescription drug costs in 2025.CNBC - Jan. 4 -
This factor makes 11 stocks look like better bargains even after they soared in 2024
Some stocks’ price-to-earnings valuations declined even as they outpaced the S&P 500’s big gain.MarketWatch - Jan. 4 -
Why Coffee Prices Are Soaring (Again)
Wholesale coffee prices are trading near a 50-year high because of shortages related to extreme weather and increased global demand.The New York Times - Jan. 4 -
Sanders gets Finance perch to push Social Security, Medicare expansion, tax reform
Sen. Bernie Sanders (I-Vt.), who supports expanding Social Security and Medicare and raising taxes on the wealthy, will get a seat on the Senate’s powerful Finance Committee, which has jurisdiction ...The Hill - Jan. 2 -
Here's what to know about Medicare's new spending cap
This year, a new spending cap on medication goes into effect for the first time for people on Medicare. CBS News medical contributor Dr. Celine Gounder explains its impact.CBS News - Jan. 2
